カテゴリー： QYResearch, 世界

世界の植物及び植物由来薬品市場：業界調査2019年

QYResearchが発行した調査報告書（DATA910T01866）
◆英語タイトル：Global Botanical and Plant-Derived Drugs Market Professional Survey Report 2019
◆商品コード：DATA910T01866
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月28日
◆ページ数：124
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：化学・材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥371,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥556,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥742,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※本調査レポートは、植物及び植物由来薬品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、テルペン及びステロイド、アルカロイド及びグリコシド、フェノール、その他に、用途別には、家禽、水産、果物及び野菜、その他にセグメント区分し、植物及び植物由来薬品の世界市場を分析しました。


・エグゼクティブ・サマリー
・植物及び植物由来薬品の世界市場概要
・植物及び植物由来薬品の製造コスト構成分析
・植物及び植物由来薬品の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・植物及び植物由来薬品の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・植物及び植物由来薬品のセグメント分析（種類別）
（テルペン及びステロイド、アルカロイド及びグリコシド、フェノール、その他）
・植物及び植物由来薬品のセグメント分析（用途別）
（家禽、水産、果物及び野菜、その他）
・植物及び植物由来薬品の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Yunnan Baiyao、Tongrentang、TASLY、Sanjiu、Zhongxin、Haiyao、Taiji、Kunming Pharma、JZJT、Guangzhou Pharma、Tsumura、Schwabe、Madaus、Weleda、Blackmores、Arkopharma、SIDO MUNCUL、Arizona Natural、Dabur、Herbal Africa、Nature’s Answer、Bio-Botanica、Potter’s、Zand、Nature Herbs、Imperial Ginseng、）
・植物及び植物由来薬品の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Botanical and Plant-Derived Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Botanical and Plant-Derived Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Botanical and Plant-Derived Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Botanical and Plant-Derived Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Botanical and Plant-Derived Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Yunnan Baiyao
Tongrentang
TASLY
Sanjiu
Zhongxin
Haiyao
Taiji
Kunming Pharma
JZJT
Guangzhou Pharma
Tsumura
Schwabe
Madaus
Weleda
Blackmores
Arkopharma
SIDO MUNCUL
Arizona Natural
Dabur
Herbal Africa
Nature’s Answer
Bio-Botanica
Potter’s
Zand
Nature Herbs
Imperial Ginseng

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Terpenes and Steroids
Alkaloids and Glycosides
Phenols
Other

Segment by Application
Poultry
Fisheries
Fruits and Vegetables
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Botanical and Plant-Derived Drugs
1.1 Definition of Botanical and Plant-Derived Drugs
1.2 Botanical and Plant-Derived Drugs Segment by Type
1.2.1 Global Botanical and Plant-Derived Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Terpenes and Steroids
1.2.3 Alkaloids and Glycosides
1.2.4 Phenols
1.2.5 Other
1.3 Botanical and Plant-Derived Drugs Segment by Applications
1.3.1 Global Botanical and Plant-Derived Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Poultry
1.3.3 Fisheries
1.3.4 Fruits and Vegetables
1.3.5 Other
1.4 Global Botanical and Plant-Derived Drugs Overall Market
1.4.1 Global Botanical and Plant-Derived Drugs Revenue (2014-2025)
1.4.2 Global Botanical and Plant-Derived Drugs Production (2014-2025)
1.4.3 North America Botanical and Plant-Derived Drugs Status and Prospect (2014-2025)
1.4.4 Europe Botanical and Plant-Derived Drugs Status and Prospect (2014-2025)
1.4.5 China Botanical and Plant-Derived Drugs Status and Prospect (2014-2025)
1.4.6 Japan Botanical and Plant-Derived Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Botanical and Plant-Derived Drugs Status and Prospect (2014-2025)
1.4.8 India Botanical and Plant-Derived Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Botanical and Plant-Derived Drugs
2.3 Manufacturing Process Analysis of Botanical and Plant-Derived Drugs
2.4 Industry Chain Structure of Botanical and Plant-Derived Drugs

3 Development and Manufacturing Plants Analysis of Botanical and Plant-Derived Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Botanical and Plant-Derived Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Botanical and Plant-Derived Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Botanical and Plant-Derived Drugs Production and Capacity Analysis
4.2 Botanical and Plant-Derived Drugs Revenue Analysis
4.3 Botanical and Plant-Derived Drugs Price Analysis
4.4 Market Concentration Degree

5 Botanical and Plant-Derived Drugs Regional Market Analysis
5.1 Botanical and Plant-Derived Drugs Production by Regions
5.1.1 Global Botanical and Plant-Derived Drugs Production by Regions
5.1.2 Global Botanical and Plant-Derived Drugs Revenue by Regions
5.2 Botanical and Plant-Derived Drugs Consumption by Regions
5.3 North America Botanical and Plant-Derived Drugs Market Analysis
5.3.1 North America Botanical and Plant-Derived Drugs Production
5.3.2 North America Botanical and Plant-Derived Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Botanical and Plant-Derived Drugs Import and Export
5.4 Europe Botanical and Plant-Derived Drugs Market Analysis
5.4.1 Europe Botanical and Plant-Derived Drugs Production
5.4.2 Europe Botanical and Plant-Derived Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Botanical and Plant-Derived Drugs Import and Export
5.5 China Botanical and Plant-Derived Drugs Market Analysis
5.5.1 China Botanical and Plant-Derived Drugs Production
5.5.2 China Botanical and Plant-Derived Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Botanical and Plant-Derived Drugs Import and Export
5.6 Japan Botanical and Plant-Derived Drugs Market Analysis
5.6.1 Japan Botanical and Plant-Derived Drugs Production
5.6.2 Japan Botanical and Plant-Derived Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Botanical and Plant-Derived Drugs Import and Export
5.7 Southeast Asia Botanical and Plant-Derived Drugs Market Analysis
5.7.1 Southeast Asia Botanical and Plant-Derived Drugs Production
5.7.2 Southeast Asia Botanical and Plant-Derived Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Botanical and Plant-Derived Drugs Import and Export
5.8 India Botanical and Plant-Derived Drugs Market Analysis
5.8.1 India Botanical and Plant-Derived Drugs Production
5.8.2 India Botanical and Plant-Derived Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Botanical and Plant-Derived Drugs Import and Export

6 Botanical and Plant-Derived Drugs Segment Market Analysis (by Type)
6.1 Global Botanical and Plant-Derived Drugs Production by Type
6.2 Global Botanical and Plant-Derived Drugs Revenue by Type
6.3 Botanical and Plant-Derived Drugs Price by Type

7 Botanical and Plant-Derived Drugs Segment Market Analysis (by Application)
7.1 Global Botanical and Plant-Derived Drugs Consumption by Application
7.2 Global Botanical and Plant-Derived Drugs Consumption Market Share by Application (2014-2019)

8 Botanical and Plant-Derived Drugs Major Manufacturers Analysis
8.1 Yunnan Baiyao
8.1.1 Yunnan Baiyao Botanical and Plant-Derived Drugs Production Sites and Area Served
8.1.2 Yunnan Baiyao Product Introduction, Application and Specification
8.1.3 Yunnan Baiyao Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Tongrentang
8.2.1 Tongrentang Botanical and Plant-Derived Drugs Production Sites and Area Served
8.2.2 Tongrentang Product Introduction, Application and Specification
8.2.3 Tongrentang Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 TASLY
8.3.1 TASLY Botanical and Plant-Derived Drugs Production Sites and Area Served
8.3.2 TASLY Product Introduction, Application and Specification
8.3.3 TASLY Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sanjiu
8.4.1 Sanjiu Botanical and Plant-Derived Drugs Production Sites and Area Served
8.4.2 Sanjiu Product Introduction, Application and Specification
8.4.3 Sanjiu Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Zhongxin
8.5.1 Zhongxin Botanical and Plant-Derived Drugs Production Sites and Area Served
8.5.2 Zhongxin Product Introduction, Application and Specification
8.5.3 Zhongxin Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Haiyao
8.6.1 Haiyao Botanical and Plant-Derived Drugs Production Sites and Area Served
8.6.2 Haiyao Product Introduction, Application and Specification
8.6.3 Haiyao Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Taiji
8.7.1 Taiji Botanical and Plant-Derived Drugs Production Sites and Area Served
8.7.2 Taiji Product Introduction, Application and Specification
8.7.3 Taiji Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Kunming Pharma
8.8.1 Kunming Pharma Botanical and Plant-Derived Drugs Production Sites and Area Served
8.8.2 Kunming Pharma Product Introduction, Application and Specification
8.8.3 Kunming Pharma Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 JZJT
8.9.1 JZJT Botanical and Plant-Derived Drugs Production Sites and Area Served
8.9.2 JZJT Product Introduction, Application and Specification
8.9.3 JZJT Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Guangzhou Pharma
8.10.1 Guangzhou Pharma Botanical and Plant-Derived Drugs Production Sites and Area Served
8.10.2 Guangzhou Pharma Product Introduction, Application and Specification
8.10.3 Guangzhou Pharma Botanical and Plant-Derived Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Tsumura
8.12 Schwabe
8.13 Madaus
8.14 Weleda
8.15 Blackmores
8.16 Arkopharma
8.17 SIDO MUNCUL
8.18 Arizona Natural
8.19 Dabur
8.20 Herbal Africa
8.21 Nature’s Answer
8.22 Bio-Botanica
8.23 Potter’s
8.24 Zand
8.25 Nature Herbs
8.26 Imperial Ginseng

9 Development Trend of Analysis of Botanical and Plant-Derived Drugs Market
9.1 Global Botanical and Plant-Derived Drugs Market Trend Analysis
9.1.1 Global Botanical and Plant-Derived Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Botanical and Plant-Derived Drugs Regional Market Trend
9.2.1 North America Botanical and Plant-Derived Drugs Forecast 2019-2025
9.2.2 Europe Botanical and Plant-Derived Drugs Forecast 2019-2025
9.2.3 China Botanical and Plant-Derived Drugs Forecast 2019-2025
9.2.4 Japan Botanical and Plant-Derived Drugs Forecast 2019-2025
9.2.5 Southeast Asia Botanical and Plant-Derived Drugs Forecast 2019-2025
9.2.6 India Botanical and Plant-Derived Drugs Forecast 2019-2025
9.3 Botanical and Plant-Derived Drugs Market Trend (Product Type)
9.4 Botanical and Plant-Derived Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Botanical and Plant-Derived Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Botanical and Plant-Derived Drugs
Table Global Botanical and Plant-Derived Drugs Production (MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Botanical and Plant-Derived Drugs Production Market Share by Types in 2018
Figure Terpenes and Steroids Product Picture
Figure Alkaloids and Glycosides Product Picture
Figure Phenols Product Picture
Figure Other Product Picture
Table Global Botanical and Plant-Derived Drugs Consumption (MT) Comparison by Applications (2014-2025)
Figure Global Botanical and Plant-Derived Drugs Consumption Market Share by Applications in 2018
Figure Poultry
Figure Fisheries
Figure Fruits and Vegetables
Figure Other
Figure Global Botanical and Plant-Derived Drugs Revenue (Million USD) (2014-2025)
Figure Global Botanical and Plant-Derived Drugs Production (MT) (2014-2025)
Figure North America Botanical and Plant-Derived Drugs Market Size (Million USD) (2014-2025)
Figure Europe Botanical and Plant-Derived Drugs Market Size (Million USD) (2014-2025)
Figure China Botanical and Plant-Derived Drugs Market Size (Million USD) (2014-2025)
Figure Japan Botanical and Plant-Derived Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Botanical and Plant-Derived Drugs Market Size (Million USD) (2014-2025)
Figure India Botanical and Plant-Derived Drugs Market Size (Million USD) (2014-2025)
Table Botanical and Plant-Derived Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Botanical and Plant-Derived Drugs in 2018
Figure Manufacturing Process Analysis of Botanical and Plant-Derived Drugs
Figure Industry Chain Structure of Botanical and Plant-Derived Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Botanical and Plant-Derived Drugs Manufacturing Plants Distribution
Table Botanical and Plant-Derived Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Botanical and Plant-Derived Drugs Capacity (MT) of Major Manufacturers (2014-2019)
Table Botanical and Plant-Derived Drugs Production (MT) of Major Manufacturers (2014-2019)
Table Botanical and Plant-Derived Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Botanical and Plant-Derived Drugs Production Share by Manufacturers in 2018
Table Botanical and Plant-Derived Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Botanical and Plant-Derived Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Botanical and Plant-Derived Drugs Revenue Share by Manufacturers in 2018
Table Botanical and Plant-Derived Drugs Average Price (USD/T) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Botanical and Plant-Derived Drugs Production by Regions 2014-2019 (MT)
Table Global Botanical and Plant-Derived Drugs Production Market Share by Regions 2014-2019
Figure Global Botanical and Plant-Derived Drugs Production Market Share by Regions in 2018
Table Global Botanical and Plant-Derived Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Botanical and Plant-Derived Drugs Revenue Market Share by Regions 2014-2019
Figure Global Botanical and Plant-Derived Drugs Revenue Market Share by Regions in 2018
Table Global Botanical and Plant-Derived Drugs Consumption by Regions 2014-2019 (MT)
Table Global Botanical and Plant-Derived Drugs Consumption Market Share by Regions 2014-2019
Figure North America Botanical and Plant-Derived Drugs Production Growth Rate 2014-2019 (MT)
Figure North America Botanical and Plant-Derived Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Botanical and Plant-Derived Drugs Production, Consumption Import and Export (MT)
Figure Europe Botanical and Plant-Derived Drugs Production Growth Rate 2014-2019 (MT)
Figure Europe Botanical and Plant-Derived Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Botanical and Plant-Derived Drugs Production, Consumption Import and Export (MT)
Figure China Botanical and Plant-Derived Drugs Production Growth Rate 2014-2019 (MT)
Figure China Botanical and Plant-Derived Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Botanical and Plant-Derived Drugs Production, Consumption Import and Export (MT)
Figure Japan Botanical and Plant-Derived Drugs Production Growth Rate 2014-2019 (MT)
Figure Japan Botanical and Plant-Derived Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Botanical and Plant-Derived Drugs Production, Consumption Import and Export (MT)
Figure Southeast Asia Botanical and Plant-Derived Drugs Production Growth Rate 2014-2019 (MT)
Figure Southeast Asia Botanical and Plant-Derived Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Botanical and Plant-Derived Drugs Production, Consumption Import and Export (MT)
Figure India Botanical and Plant-Derived Drugs Production Growth Rate 2014-2019 (MT)
Figure India Botanical and Plant-Derived Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Botanical and Plant-Derived Drugs Production, Consumption Import and Export (MT)
Figure Global Consumption Botanical and Plant-Derived Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Botanical and Plant-Derived Drugs Market Share by Application (2014-2019)
Table Yunnan Baiyao Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Yunnan Baiyao Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table Yunnan Baiyao Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table Yunnan Baiyao Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table Yunnan Baiyao Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure Yunnan Baiyao Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table Yunnan Baiyao Botanical and Plant-Derived Drugs Main Business and Markets Served
Table Tongrentang Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Tongrentang Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table Tongrentang Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table Tongrentang Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table Tongrentang Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure Tongrentang Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table Tongrentang Botanical and Plant-Derived Drugs Main Business and Markets Served
Table TASLY Botanical and Plant-Derived Drugs Production Sites and Area Served
Table TASLY Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table TASLY Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table TASLY Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table TASLY Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure TASLY Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table TASLY Botanical and Plant-Derived Drugs Main Business and Markets Served
Table Sanjiu Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Sanjiu Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table Sanjiu Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table Sanjiu Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table Sanjiu Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure Sanjiu Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table Sanjiu Botanical and Plant-Derived Drugs Main Business and Markets Served
Table Zhongxin Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Zhongxin Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table Zhongxin Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table Zhongxin Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table Zhongxin Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure Zhongxin Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table Zhongxin Botanical and Plant-Derived Drugs Main Business and Markets Served
Table Haiyao Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Haiyao Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table Haiyao Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table Haiyao Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table Haiyao Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure Haiyao Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table Haiyao Botanical and Plant-Derived Drugs Main Business and Markets Served
Table Taiji Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Taiji Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table Taiji Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table Taiji Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table Taiji Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure Taiji Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table Taiji Botanical and Plant-Derived Drugs Main Business and Markets Served
Table Kunming Pharma Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Kunming Pharma Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table Kunming Pharma Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table Kunming Pharma Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table Kunming Pharma Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure Kunming Pharma Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table Kunming Pharma Botanical and Plant-Derived Drugs Main Business and Markets Served
Table JZJT Botanical and Plant-Derived Drugs Production Sites and Area Served
Table JZJT Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table JZJT Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table JZJT Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table JZJT Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure JZJT Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table JZJT Botanical and Plant-Derived Drugs Main Business and Markets Served
Table Guangzhou Pharma Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Guangzhou Pharma Botanical and Plant-Derived Drugs Product Introduction, Application and Specification
Table Guangzhou Pharma Botanical and Plant-Derived Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/T) and Gross Margin (2014-2019)
Table Guangzhou Pharma Botanical and Plant-Derived Drugs Production Growth Rate (2014-2019)
Table Guangzhou Pharma Botanical and Plant-Derived Drugs Production Market Share (2014-2019)
Figure Guangzhou Pharma Botanical and Plant-Derived Drugs Revenue Market Share (2014-2019)
Table Guangzhou Pharma Botanical and Plant-Derived Drugs Main Business and Markets Served
Table Tsumura Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Schwabe Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Madaus Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Weleda Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Blackmores Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Arkopharma Botanical and Plant-Derived Drugs Production Sites and Area Served
Table SIDO MUNCUL Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Arizona Natural Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Dabur Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Herbal Africa Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Nature’s Answer Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Bio-Botanica Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Potter’s Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Zand Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Nature Herbs Botanical and Plant-Derived Drugs Production Sites and Area Served
Table Imperial Ginseng Botanical and Plant-Derived Drugs Production Sites and Area Served
Figure Global Botanical and Plant-Derived Drugs Production (MT) Growth Rate Forecast 2019-2025
Figure Global Botanical and Plant-Derived Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Botanical and Plant-Derived Drugs Sales Price (USD/T) Forecast 2019-2025
Figure North America Botanical and Plant-Derived Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure North America Botanical and Plant-Derived Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Botanical and Plant-Derived Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure Europe Botanical and Plant-Derived Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Botanical and Plant-Derived Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure China Botanical and Plant-Derived Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Botanical and Plant-Derived Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure Japan Botanical and Plant-Derived Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Botanical and Plant-Derived Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure Southeast Asia Botanical and Plant-Derived Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Botanical and Plant-Derived Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure India Botanical and Plant-Derived Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (MT) of Botanical and Plant-Derived Drugs by Type (2019-2025)
Table Global Consumption (MT) of Botanical and Plant-Derived Drugs by Application (2019-2025)
Table Botanical and Plant-Derived Drugs Distributors List
Table Botanical and Plant-Derived Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Yunnan Baiyao、Tongrentang、TASLY、Sanjiu、Zhongxin、Haiyao、Taiji、Kunming Pharma、JZJT、Guangzhou Pharma、Tsumura、Schwabe、Madaus、Weleda、Blackmores、Arkopharma、SIDO MUNCUL、Arizona Natural、Dabur、Herbal Africa、Nature’s Answer、Bio-Botanica、Potter’s、Zand、Nature Herbs、Imperial Ginseng、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の植物及び植物由来薬品市場：業界調査2019年(Global Botanical and Plant-Derived Drugs Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の胃腸薬市場：業界調査2019年 Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders. The global Gastrointestinal Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Gastrointestinal Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastrointestinal Drugs market size by analyzing historical...
  • 化学療法誘発性血小板減少薬の世界市場：規模・現状・予測 Chemotherapy is the cancer treatment given to patients with different forms of the cancer. Various drugs such as alkylating agents, antimetabolites, targeted therapy, immunotherapy drugs, etc. are used for the cancer treatment. These chemotherapy agents acts against the cancerous as well as normal cells, resulting in decreased number of the cells of all types in the body. Cancer therapy which results in the killing of normal thrombocytes resulting in decreased number of normally functioning thrombocytes, the condition is called as the chemotherapy induced thrombocytopenia.In 2018, the global Chemotherapy Induced Thrombocytopenia Drugs market size was xx million US$ and it is...
  • 世界のオピオイド作動薬市場：業界調査2019年 Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth The global Opioids Agonist Drugs market was valued at 18600 million US$ in 2018 and will reach 25900 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2019-2025. This report focuses on Opioids Agonist Drugs volume and value at global level, regional level and company level. From...
  • 世界の細胞障害性薬物市場：業界調査2019年 Cytotoxic drugs are being used as a potent drug in cancer treatment. Cytotoxic drugs are also used in developing ADCs (antibody-drug conjugates): There are two types of cytotoxic agents available currently, one is DNA modifying agents and the other is microtubule disrupting agents which effects the cell cycle in order restrict them to multiply and unlike drugs of category which are cell life cycle specific, DNA modifying agents kill cells at any point. Cytotoxic Drugs included in the report are products that are used for cancer treatment and research.In the drug type category for cytotoxic drugs, antimetabolites is the leading...
  • 世界の制吐薬市場：業界調査2019年 An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of...
  • 世界のカルダモンオレオレジン市場：業界調査2019年 Cardamom oleoresin is a flavor extract obtained from the seeds of cardamom fruit, just before its ripening stage. The oleoresin is obtained through extraction with the help of a solvent. Cardamom oleoresin is a yellow colored liquid having a sweet & spicy fragrance. It is primarily used in food preparations as a food condiment, or as a spice which is added to enhance the flavor of a dish.  It is also known to have medicinal properties and is listed in the British Herbal Pharmacopoeia, as a 'specific' for dyspepsia and flatulence.On the backdrop of rising consumer awareness about the use...
  • 世界の生活改善薬市場：業界調査2019年 Lifestyle drug is an term commonly applied to medications which treat non–life-threatening and non-painful conditions such as baldness, wrinkles, erectile dysfunction, or acne, which the speaker perceives as either not medical problems at all or as minor medical conditions relative to others. Proponents point out that improving the patient's subjective quality of life has always been a primary concern of medicine.There is direct impact of lifestyle drugs on society, particularly in the developing world. Implications associated with labeling of indications and products sales of these lifestyle drugs may be varied. Drugs can, over time, switch from 'lifestyle' to 'mainstream' use....
  • 世界の乳製品由来フレーバー市場：業界調査2019年 The organoleptic properties of dairy products coupled with their image among consumer as a healthy halo make them one of the most desirable ingredients in the food and beverage industry. Dairy derived flavors are processed from dairy and are designed to increase the intensity of dairy top notes in a product. Dairy derived flavors are also being used in combination with other characterizing flavors to deliver a complete taste profile to the final product even when there are no dairy ingredients in the formulation of the product.Rising demand for specialty dairy products such as feta cheese has increased the traction...
  • 勃起不全治療薬の世界市場：規模・現状・予測 Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being associated with certain risk factors such as usage of tobacco and alcohol, certain medications and medical treatment, injuries and psychological conditions.In 2018, the global Erectile Dysfunction Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the...
  • サイトメガロウイルス（HHV-5）感染症治療薬の世界市場：規模・現状・予測 A drug used to treat giant cell infections.In 2018, the global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cytomegalovirus（HHV-5）Infection Therapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study 3-V Biosciences, Inc. AIMM Therapeutics AlphaVax Altor BioScience...
  • 良性前立腺過形成薬剤の世界市場：規模・現状・予測 The goal of Benign prostate hyperplasia drugs is to reduce morbidity and prevent complications.Agents used include alpha-adrenergic blockers, 5-alpha-reductase inhibitors, phosphodiesterase -5 inhibitors and various combinations.In 2018, the global Benign Prostate Hyperplasia Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Benign Prostate Hyperplasia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Benign Prostate Hyperplasia Drugs development in North America, Europe, China, Japan, Southeast Asia,...
  • 腎移植治療薬の世界市場：規模・現状・予測 Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body.In 2018, the global Transplantation Therapeutics Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Transplantation Therapeutics Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transplantation Therapeutics Drugs development in North America, Europe and Asia-Pacific. The key players covered in...
  • 心理療法薬の世界市場：規模・現状・予測 Psychotherapy is a collaborative approach used by psychologists to help people overcome various mental illnesses and emotional difficulties.In 2018, the global Psychotherapeutic Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Psychotherapeutic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psychotherapeutic Drugs development in North America, Europe and Asia-Pacific. The key players covered in this study Eli Lilly Johnson&Johnson Pfizer Bristol-Myers Squibb Allergan GlaxoSmithKline AstraZeneca...
  • 非インスリン抗糖尿病薬の世界市場：規模・現状・予測 Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes).In 2018, the global Non Insulin Anti diabetes Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Non Insulin Anti diabetes Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non Insulin Anti diabetes Drugs development in North America,...
  • 大分子注射薬の世界市場：規模・現状・予測 Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect.In 2018, the global Large Molecule Injectable Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Large Molecule Injectable Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Large Molecule Injectable Drugs development in North America, Europe and Asia-Pacific. The key players covered in this study...